Schwaneke Jeffrey A.
Known title: DirectorCIK: 0001446919
Schwaneke Jeffrey A.'s purchase track record
Schwaneke Jeffrey A. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/29/2023 | AGL | $250K | -40.5% | -46.1% | +15.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AGL | ▼ Sell | Tax Withholding | 2,311 | $258K | 7/1/2026 | View on chart |
| AGL | ▼ Sell | Tax Withholding | 1,662 | $16K | 4/1/2026 | View on chart |
| AGL | ▲ Buy | Grant | 75,000 | $0 | 4/1/2026 | View on chart |
| AGL | ▲ Buy | Grant | 600,000 | $0 | 1/10/2026 | View on chart |
| AGL | ▼ Sell | Tax Withholding | 46,099 | $110K | 7/1/2025 | View on chart |
| AGL | ▼ Sell | Tax Withholding | 9,331 | $22K | 5/28/2025 | View on chart |
| AGL | ▲ Buy | Grant | 150,830 | $0 | 7/1/2024 | View on chart |
| AGL | ▲ Buy | Grant | 131,976 | $0 | 7/1/2024 | View on chart |
| AGL | ▲ Buy | Grant | 377,074 | $0 | 7/1/2024 | View on chart |
| AGL | ▲ Buy | Grant | 32,119 | $0 | 5/29/2024 | View on chart |
| AGL | ▲ Buy | Open Market | 22,300 | $250K | 11/29/2023 | View on chart |
| AGL | ▲ Buy | Grant | 5,622 | $0 | 4/14/2023 | View on chart |
| AGL | ▲ Buy | Grant | 4,009 | $0 | 8/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Agilon Health Stock Moves Amid Peer Comparison
Recent market activity for Agilon Health has drawn attention to how its performance compares with other medical sector stocks this year. The company's stock is currently trading near a significant support level, which may be influencing investor sentiment. Analysts maintain a wide range of price targets, reflecting varying views on the company's future trajectory.
Agilon Health Stock Moves Amid Peer Comparison. Recent market activity for Agilon Health has drawn attention to how its performance compares with other medical sector stocks this year. The company's stock is currently trading near a significant support level, which may be influencing investor sentiment. Analysts maintain a wide range of price targets, reflecting varying views on the company's future trajectory.